Page last updated: 2024-08-24

ranolazine and Angina, Stable

ranolazine has been researched along with Angina, Stable in 50 studies

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (4.00)29.6817
2010's43 (86.00)24.3611
2020's5 (10.00)2.80

Authors

AuthorsStudies
Lopez-Sendon, J; Tamargo, J1
Dechend, R1
Cesar, LAM; Dourado, LOC; Gowdak, LHW; Grobe, SF; Moreno, CPD1
Ayyasamy, L; Bagepally, BS1
Abacioglu, N; Chukwunyere, U; Sehirli, AO1
Ahmed, B; Clegg, S; Mondragon, J; Sheldon, M1
Balla, C; Ferrari, R; Pavasini, R1
Coleman, CI; Kohn, CG; Nguyen, E; Weeda, ER1
Bress, AP; Crook, J; Dodson, JA; Greene, T; King, JB; Knippenberg, K; LaFleur, J; Munger, MA; Nelson, RE; Radwanski, P; Reese, T; Sauer, BC; Weintraub, WS1
Bleske, BE; Eyler, RF; Heung, M; Mueller, BA; Salama, NN; Scoville, BA; Segal, JH1
Aichinger, J; Delle-Karth, G; Lang, I; Metzler, B; Wallner, E; Zweiker, R1
Arnold, SV; Belardinelli, L; Ben-Yehuda, O; Chaitman, BR; Jones, PG; Katz, A; Kosiborod, M; Li, Y; McGuire, DK; Olmsted, A; Spertus, JA; Yue, P1
DeMaria, AN; Lew, WY1
Rumsfeld, JS1
Trujillo, TC1
Bacchini, S; Barbieri, L; Bongo, AS; Cavallino, C; Degiovanni, A; Lazzero, M; Lupi, A; Nardi, F; Rametta, F; Rognoni, A; Veia, A1
Grehan, S; Muhlestein, JB1
Carbone, F; Mach, F; Montecucco, F1
Geunes-Boyer, S; Hines, ME; Kloner, RA1
Banon, D; Budlovsky, T; Eisenberg, MJ; Filion, KB; Franck, C1
Coleman, CI; Kohn, CG; Limone, BL; Parker, MW2
Biscaglia, S; Valgimigli, M1
Aronow, WS; Khera, S; Kolte, D1
Arnold, SV; Ben-Yehuda, O; Kosiborod, M; Li, Y; McGuire, DK; Spertus, JA; Yue, P1
Arnold, SV; Belardinelli, L; Ben-Yehuda, O; Chaitman, BR; Jones, PG; Kosiborod, M; Li, Y; McGuire, DK; Olmsted, A; Spertus, JA; Yue, P1
Castriota, F; Cremonesi, A; De Luca, G; Fattori, R; Lupi, A; Marino, PN; Mirabella, F; Parisi, R; Rognoni, A; Secco, GG1
Dixit, D; Kimborowicz, K1
Rognoni, A1
Ghushchyan, V; Hartsfield, CL; Koch, BR; Nair, KV; Page, RL; Read, RA1
Arnold, SV; Belardinelli, L; Chaitman, BR; Inzucchi, SE; Kosiborod, M; McGuire, DK; Spertus, JA; Tang, F; Yue, P1
Blum, A1
Coleman, CI; Freemantle, N; Kohn, CG1
Afthonidis, D; Alexopoulos, D; Barbetseas, J; Kelembekoglou, P; Kochiadakis, G; Limberi, S; Spanos, A; Triantafyllidis, G1
Cacciapuoti, F1
Rayner-Hartley, E; Sedlak, T1
Kourlaba, G; Maniadakis, N; Vardas, P; Vellopoulou, K1
Ohman, EM1
Rosano, GMC; Vitale, C; Volterrani, M1
Vitaliivna Kuzminova, N; Yuriivna Osovska, N1
Basilio Flores, JE; Loza Munárriz, C; Mejia Dolores, JW; Rey Rodriguez, DE; Salazar, CA; Veramendi Espinoza, LE1
Melloni, C; Newby, LK; Truffa, AA1
Franck, AJ; Frohnapple, DJ; Gillette, MA; Reeder, DN1
Ben-Yehuda, O; Cheng, ML; Lee, S; Sendón, JL1
De Silva, R; Purcell, H1
Biasillo, G; Cardillo, MT; Della Bona, R; Gustapane, M1
Demare, P; Hernández-Díaz, C; Mascher, D; Monsalvo, I; Paredes-Carbajal, MC; Regla, I1
Di Monaco, A; Sestito, A1
Stone, PH; Wimmer, NJ1
Keating, GM1

Reviews

22 review(s) available for ranolazine and Angina, Stable

ArticleYear
Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina.
    Future cardiology, 2022, Volume: 18, Issue:3

    Topics: Acetanilides; Angina, Stable; Coronary Artery Disease; Humans; Piperazines; Quality of Life; Ranolazine

2022
Cost-utility of Ranolazine for Chronic Stable Angina Pectoris: Systematic Review and Meta-analysis.
    Clinical therapeutics, 2023, Volume: 45, Issue:5

    Topics: Acetanilides; Angina, Stable; Cost-Benefit Analysis; Humans; Myocardial Ischemia; Ranolazine

2023
Treatment of Angina: Where Are We?
    Cardiology, 2018, Volume: 140, Issue:1

    Topics: Adrenergic beta-Antagonists; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Chest Pain; Humans; Ivabradine; Nicorandil; Patient Selection; Practice Guidelines as Topic; Ranolazine; Treatment Outcome; Trimetazidine

2018
Ranolazine: effects on ischemic heart.
    Recent patents on cardiovascular drug discovery, 2013, Volume: 8, Issue:3

    Topics: Acetanilides; Angina, Stable; Animals; Arrhythmias, Cardiac; Clinical Trials as Topic; Diabetes Mellitus; Drug Interactions; Heart Failure; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Sodium Channel Blockers

2013
Update on evidence for treatment with ranolazine in stable angina.
    Swiss medical weekly, 2013, Volume: 143

    Topics: Acetanilides; Angina, Stable; Humans; Piperazines; Ranolazine; Sodium Channel Blockers; Treatment Outcome

2013
Efficacy and safety of ranolazine in patients with chronic stable angina.
    Postgraduate medicine, 2013, Volume: 125, Issue:6

    Topics: Acetanilides; Angina, Stable; Arrhythmias, Cardiac; Diabetes Mellitus, Type 2; Drug Interactions; Electrocardiography; Enzyme Inhibitors; Geriatrics; Glycated Hemoglobin; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine

2013
The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
    The American journal of cardiology, 2014, Mar-15, Volume: 113, Issue:6

    Topics: Acetanilides; Angina, Stable; Chronic Disease; Enzyme Inhibitors; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome

2014
Stable angina pectoris.
    Current atherosclerosis reports, 2014, Volume: 16, Issue:7

    Topics: Acetanilides; Angina, Stable; Benzazepines; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vasospasm; Echocardiography, Stress; Exercise Test; Humans; Ivabradine; Microvessels; Nicorandil; Nitrates; Percutaneous Coronary Intervention; Piperazines; Ranolazine; Smoking Cessation; Vasodilator Agents

2014
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization.
    Cardiovascular & hematological agents in medicinal chemistry, 2015, Volume: 13, Issue:1

    Topics: Angina, Stable; Animals; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Trimetazidine

2015
Pharmacologic management of chronic stable angina.
    JAAPA : official journal of the American Academy of Physician Assistants, 2015, Volume: 28, Issue:6

    Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents

2015
Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.
    Therapeutic advances in cardiovascular disease, 2016, Volume: 10, Issue:2

    Topics: Angina, Stable; Benzazepines; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Oxygen Consumption; Ranolazine

2016
Ranolazine: A Contemporary Review.
    Journal of the American Heart Association, 2016, Mar-15, Volume: 5, Issue:3

    Topics: Angina, Stable; Animals; Cardiovascular Agents; Chronic Disease; Drug Interactions; Drug Labeling; Humans; Off-Label Use; Practice Guidelines as Topic; Ranolazine; Sodium Channel Blockers; Treatment Outcome

2016
A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris.
    International journal of cardiology, 2016, May-15, Volume: 211

    Topics: Angina, Stable; Cardiovascular Agents; Cost-Benefit Analysis; Humans; Ranolazine; Treatment Outcome

2016
CLINICAL PRACTICE. Chronic Stable Angina.
    The New England journal of medicine, 2016, Mar-24, Volume: 374, Issue:12

    Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Coronary Artery Disease; Humans; Male; Myocardial Revascularization; Nitrates; Practice Guidelines as Topic; Ranolazine

2016
Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
    Cardiovascular drugs and therapy, 2016, Volume: 30, Issue:4

    Topics: Angina, Stable; Animals; Cardiovascular Agents; Humans; Ranolazine

2016
Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2016, Dec-22, Volume: 41, Issue:246

    Topics: Adult; Angina, Stable; Atrial Fibrillation; Bundle-Branch Block; Cardiovascular Agents; Female; Humans; Microvascular Angina; Middle Aged; Ranolazine; Treatment Outcome

2016
Ranolazine for stable angina pectoris.
    The Cochrane database of systematic reviews, 2017, Feb-08, Volume: 2

    Topics: Angina, Stable; Cardiovascular Agents; Cause of Death; Humans; Incidence; Middle Aged; Myocardial Infarction; Quality of Life; Randomized Controlled Trials as Topic; Ranolazine

2017
Extended-release ranolazine: critical evaluation of its use in stable angina.
    Vascular health and risk management, 2011, Volume: 7

    Topics: Acetanilides; Angina, Stable; Animals; Cardiovascular Agents; Delayed-Action Preparations; Humans; Piperazines; Quality of Life; Ranolazine; Treatment Outcome

2011
[Ranolazine in the treatment of chronic stable angina].
    La Clinica terapeutica, 2012, Volume: 163, Issue:3

    Topics: Acetanilides; Angina, Stable; Cardiovascular System; Humans; Piperazines; Ranolazine

2012
The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.
    European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:12

    Topics: Acetanilides; Adrenergic beta-Antagonists; Angina, Stable; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chronic Disease; Coronary Artery Bypass; Disease Management; Heart Function Tests; Humans; Membrane Transport Modulators; Myocardial Ischemia; Nitrates; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Ranolazine

2012
Anti-anginal and anti-ischemic effects of late sodium current inhibition.
    Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:1

    Topics: Acetanilides; Angina, Stable; Clinical Trials as Topic; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Sodium Channel Blockers; Sodium Channels; Treatment Outcome

2013
Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.
    Drugs, 2013, Volume: 73, Issue:1

    Topics: Acetanilides; Angina, Stable; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Piperazines; Ranolazine; Treatment Outcome

2013

Trials

8 trial(s) available for ranolazine and Angina, Stable

ArticleYear
Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis.
    Renal failure, 2019, Volume: 41, Issue:1

    Topics: Administration, Oral; Adult; Angina, Stable; Area Under Curve; Biological Variation, Population; Cardiovascular Agents; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pilot Projects; Prospective Studies; Ranolazine; Renal Dialysis; Tablets; Young Adult

2019
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
    Journal of the American College of Cardiology, 2013, May-21, Volume: 61, Issue:20

    Topics: Acetanilides; Aged; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Sodium Channel Blockers; Treatment Outcome; Vasodilator Agents

2013
Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.
    The American journal of cardiology, 2014, Apr-15, Volume: 113, Issue:8

    Topics: Acetanilides; Angina, Stable; Chronic Disease; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Costs; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Male; Piperazines; Quality-Adjusted Life Years; Ranolazine; Standard of Care; United States

2014
Impact of angina frequency on health utility values of patients with chronic stable angina.
    Health and quality of life outcomes, 2014, Mar-14, Volume: 12

    Topics: Acetanilides; Angina, Stable; Chronic Disease; Double-Blind Method; Enzyme Inhibitors; Female; Health Status Indicators; Humans; Male; Middle Aged; Piperazines; Placebos; Quality of Life; Ranolazine; Surveys and Questionnaires; Time Factors; Treatment Outcome; United States

2014
Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.
    JAMA internal medicine, 2014, Volume: 174, Issue:8

    Topics: Acetanilides; Aged; Angina, Stable; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitroglycerin; Patient Satisfaction; Piperazines; Quality of Life; Ranolazine; Treatment Outcome; Vasodilator Agents

2014
Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.
    American heart journal, 2014, Volume: 168, Issue:4

    Topics: Acetanilides; Angina, Stable; Chronic Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Treatment Outcome

2014
Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.
    American heart journal, 2015, Volume: 170, Issue:4

    Topics: Aged; Angina, Stable; Blood Glucose; Cardiovascular Agents; Chronic Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Ranolazine; Retrospective Studies

2015
Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
    European journal of preventive cardiology, 2012, Volume: 19, Issue:5

    Topics: Acetanilides; Angina, Stable; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Enzyme Inhibitors; Exercise Test; Exercise Tolerance; Follow-Up Studies; Humans; Incidence; Piperazines; Prospective Studies; Ranolazine; Spain; Treatment Outcome

2012

Other Studies

20 other study(ies) available for ranolazine and Angina, Stable

ArticleYear
[Diagnostics, therapy and the importance of quality of life in patients with chronic coronary syndrome. Results oft the general practitioner care study ALTHEA].
    MMW Fortschritte der Medizin, 2022, Volume: 164, Issue:Suppl 6

    Topics: Angina, Stable; Coronary Artery Disease; Cross-Sectional Studies; General Practitioners; Humans; Quality of Life; Ranolazine; Syndrome

2022
Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience.
    Arquivos brasileiros de cardiologia, 2022, Volume: 119, Issue:4

    Topics: Angina Pectoris; Angina, Stable; Cardiovascular Agents; Humans; Ranolazine; Treatment Outcome; Trimetazidine; Vasodilator Agents

2022
COVID-19-related arrhythmias and the possible effects of ranolazine.
    Medical hypotheses, 2021, Volume: 149

    Topics: Action Potentials; Angina, Stable; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; COVID-19; COVID-19 Drug Treatment; Cytokines; Hemodynamics; Humans; Inflammation; Potassium Channels; Ranolazine; Sodium Channel Blockers

2021
Impact of ranolazine on coronary microvascular dysfunction (MICRO) study.
    Cardiovascular revascularization medicine : including molecular interventions, 2017, Volume: 18, Issue:6

    Topics: Aged; Angina, Stable; Cardiovascular Agents; Coronary Disease; Female; Humans; Male; Microcirculation; Middle Aged; Pilot Projects; Ranolazine; Treatment Outcome

2017
Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
    International journal of cardiology, 2018, Dec-15, Volume: 273

    Topics: Angina, Stable; Cardiovascular Agents; Cohort Studies; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Humans; Male; Markov Chains; Prospective Studies; Quality of Life; Ranolazine

2018
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
    The American journal of cardiology, 2018, 12-01, Volume: 122, Issue:11

    Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Female; Follow-Up Studies; Health Care Costs; Humans; Male; Ranolazine; Retrospective Studies; Time Factors; Treatment Outcome; United States; Veterans

2018
Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study.
    Wiener klinische Wochenschrift, 2019, Volume: 131, Issue:7-8

    Topics: Adult; Aged; Aged, 80 and over; Angina, Stable; Austria; Female; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Ranolazine; Treatment Outcome

2019
Diabetes and coronary disease: a need for new therapies for an expanding disease burden.
    Journal of the American College of Cardiology, 2013, May-21, Volume: 61, Issue:20

    Topics: Acetanilides; Angina, Stable; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Humans; Male; Piperazines; Ranolazine; Sodium Channel Blockers

2013
Introduction: Managing patients with chronic angina: emerging therapeutic options for improving clinical efficacy and outcomes.
    Journal of managed care pharmacy : JMCP, 2006, Volume: 12, Issue:8 Suppl

    Topics: Acetanilides; Angina, Stable; Cardiovascular Agents; Chronic Disease; Health Care Costs; Humans; Piperazines; Ranolazine

2006
Advances in the management of stable angina.
    Journal of managed care pharmacy : JMCP, 2006, Volume: 12, Issue:8 Suppl

    Topics: Acetanilides; Angina, Stable; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chronic Disease; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Humans; Long QT Syndrome; Piperazines; Ranolazine

2006
Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.
    Drugs in R&D, 2013, Volume: 13, Issue:3

    Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Angina, Stable; Chronic Disease; Female; Humans; Male; Middle Aged; Piperazines; Practice Guidelines as Topic; Quality of Life; Ranolazine; Severity of Illness Index; Sodium Channel Blockers; Surveys and Questionnaires; Treatment Outcome

2013
Use of ranolazine in patients with stable angina pectoris.
    Cardiology, 2014, Volume: 128, Issue:3

    Topics: Acetanilides; Adrenergic beta-Antagonists; Angina, Stable; Calcium Channel Blockers; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Glycated Hemoglobin; Humans; Nitrates; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome

2014
Old and New Drugs for Treatment of Stable Angina.
    Cardiovascular & hematological agents in medicinal chemistry, 2015, Volume: 13, Issue:1

    Topics: Adrenergic beta-Antagonists; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Drug Discovery; Humans; Nitrates; Ranolazine

2015
Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
    The American journal of cardiology, 2015, Nov-01, Volume: 116, Issue:9

    Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Comparative Effectiveness Research; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Health Resources; Humans; Male; Nitroglycerin; Ranolazine; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vasodilator Agents

2015
New oral nitric oxide-dependent medications for patients with coronary artery disease who have persistent angina pectoris.
    Coronary artery disease, 2015, Volume: 26, Issue:8

    Topics: Administration, Oral; Angina, Stable; Coronary Artery Disease; Humans; Nitric Oxide; Ranolazine; Sodium Channel Blockers; Trimetazidine; Vasodilator Agents

2015
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
    BMJ open, 2015, Nov-06, Volume: 5, Issue:11

    Topics: Aged; Angina, Stable; Cardiovascular Agents; Chronic Disease; Cost-Benefit Analysis; Drug Costs; Female; Humans; Male; Quality of Life; Quality-Adjusted Life Years; Ranolazine; Sodium Channel Blockers; Surveys and Questionnaires; United Kingdom

2015
Ranolazine reduces angina frequency and severity and improves quality of life: Observational study in patients with chronic angina under ranolazine treatment in Greece (OSCAR-GR).
    International journal of cardiology, 2016, Feb-15, Volume: 205

    Topics: Aged; Aged, 80 and over; Angina, Stable; Cardiovascular Agents; Female; Follow-Up Studies; Greece; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Quality of Life; Ranolazine; Severity of Illness Index; Treatment Outcome

2016
Clinical experience with ranolazine in a veteran population with chronic stable angina.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:1

    Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina, Stable; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents; Veterans

2012
Treating stable angina - is there a NICE way towards an international consensus?
    International journal of clinical practice, 2012, Volume: 66, Issue:7

    Topics: Acetanilides; Angina, Stable; Anti-Arrhythmia Agents; Benzazepines; Cardiac Imaging Techniques; Consensus; Humans; International Cooperation; Ivabradine; Myocardial Revascularization; Nicorandil; Piperazines; Practice Guidelines as Topic; Ranolazine; Vasodilator Agents

2012
Effects of ranolazine on vasomotor responses of rat aortic rings.
    Archives of medical research, 2013, Volume: 44, Issue:1

    Topics: Acetanilides; Angina, Stable; Animals; Aorta; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Piperazines; Ranolazine; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2013